Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

Go back to Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
VERASTEM SHS (NASDAQ: VSTM) Delayed: 4.32 +0.07 (1.65%)
Previous Close $4.25    52 Week High $2.43 
Open $4.19    52 Week Low $1.05 
Day High $4.41    P/E N/A 
Day Low $4.19    EPS $-1.79 
Volume 558,569